Phathom Pharmaceuticals (PHAT) Stock Chart & Stock Price History $9.04 +0.07 (+0.78%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$9.06 +0.02 (+0.17%) As of 06/11/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Phathom Pharmaceuticals Stock Price Performance The Phathom Pharmaceuticals (PHAT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 16.84%, with a year-to-date return of 11.33%. In the past month, the stock has increased 186.98%, reflecting recent market activity. As of the latest close, Phathom Pharmaceuticals traded at $9.04 with a market cap of $631.12 million and volume of 4.48 million shares. Five years ago, the stock traded at $48.54, representing a 81.38% decrease over that period. At the time, it had a market cap of $1.45 billion and a volume of 81,500 shares. Receive PHAT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Phathom Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.35%1 Month Performance+186.98%3 Month Performance+80.80%Year-To-Date Performance+11.33%1 Year Performance-16.84%5 Year Performance-81.38% PHAT Stock Chart for Thursday, June, 12, 2025 PHAT Chart by TradingView Phathom Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2025$8.97$9.04+0.78%$10.13$8.614.48 million shs$631.12 million06/10/2025$8.83$8.97+1.59%$9.50$8.313.56 million shs$626.23 million06/09/2025$8.92$8.83-1.01%$10.05$8.008.96 million shs$616.46 million06/06/2025$4.69$8.92+90.19%$12.32$4.7153.21 million shs$622.74 million06/05/2025$4.70$4.69-0.21%$4.87$4.47631,792 shs$327.43 million06/04/2025$4.95$4.70-5.05%$4.99$4.61823,937 shs$328.13 million06/03/2025$4.64$4.95+6.68%$4.98$4.51987,253 shs$345.58 million06/02/2025$4.24$4.64+9.43%$4.69$4.25800,228 shs$323.94 million05/30/2025$4.31$4.24-1.62%$4.30$4.051.13 million shs$296.01 million05/29/2025$4.08$4.31+5.64%$4.34$4.06850,476 shs$300.90 million Get the Latest News and Ratings for PHAT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Phathom Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/28/2025$4.12$4.08-0.97%$4.18$3.921.22 million shs$284.84 million05/27/2025$4.02$4.12+2.49%$4.20$4.03815,301 shs$287.63 million05/26/2025$4.02$4.02$4.22$3.96786,735 shs$280.65 million05/23/2025$4.23$4.02-4.96%$4.22$3.96786,735 shs$280.65 million05/22/2025$3.90$4.23+8.46%$4.24$3.70765,849 shs$295.31 million05/21/2025$4.38$3.90-10.96%$4.36$3.691.18 million shs$272.28 million05/20/2025$4.39$4.38-0.23%$4.49$4.16790,721 shs$305.79 million05/19/2025$4.09$4.39+7.33%$4.49$4.021.70 million shs$306.48 million05/16/2025$3.48$4.09+17.53%$4.14$3.531.92 million shs$285.54 million05/15/2025$3.25$3.48+7.08%$3.57$3.101.23 million shs$242.95 million05/14/2025$3.31$3.25-1.81%$3.65$3.202.07 million shs$226.90 million05/13/2025$3.15$3.31+5.08%$3.34$3.021.17 million shs$231.08 million05/12/2025$3.14$3.15+0.32%$3.39$2.822.88 million shs$219.91 million Related Companies Ocular Therapeutix Stock Price Chart Qilian International Holding Group Stock Price Chart Structure Therapeutics Stock Price Chart Amphastar Pharmaceuticals Stock Price Chart Calliditas Therapeutics AB (publ) Stock Price Chart Aurinia Pharmaceuticals Stock Price Chart CureVac Stock Price Chart Mineralys Therapeutics Stock Price Chart Phibro Animal Health Stock Price Chart Arcus Biosciences Stock Price Chart Receive PHAT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Phathom Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PHAT) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredAnother market crash is coming - here's whenMagnificent 7 Wipeout: What's Next? The first quarter stock crash and quick recovery has many people confus...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phathom Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Phathom Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PHAT Stock Free PHAT Stock Alerts